At a glance
ClinicalIndex Comparison RecordPhase 4Completed· 48 enrolled
Drug / intervention
Santyl +1 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Comparison of Sharp Surgical Debridement Versus Collagenase Santyl Ointment in the Care of Diabetic Foot Wounds
In Brief
A Phase 4 clinical trial evaluating Santyl and Control for Diabetic Foot Ulcers and Foot Wounds. Completed, enrolled 48 participants across 9 sites.
Detailed Summary
This study tests two different approaches to the removal of dead tissue from the surface of a wound.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsDiabetic Foot Ulcers, Foot Wounds
CountriesUnited States
Collaborators--
Timeline
Phase 4CompletedFinished
20102011201220132014201520162017201820192020202120222023202420252026
First PostedJan 2010
Enrollment StartFeb 2010
Primary CompletionAug 2011
Study CompletionNov 2011
TodayJul 2026
First PostedJan 26, 2010
Enrollment StartFeb 1, 2010
Primary CompletionAug 1, 2011
Study CompletionNov 1, 2011
TodayJul 2, 2026
Enrollment to primary: 1.5 yearsPosted 16.4 years ago
Interventions
Santyldrug
2 mm Santyl applied once daily.
Controlprocedure
Daily gauze and optional sharp debridement